THE

TOHOKU JOURNAL

OF

EXPERIMENTAL MEDICINE

Since 1920


Vol.263 No. 3 JULY 2024

(Go to the top page)

CONTENTS

Review
Efficacy and Safety of Neoadjuvant Pyrotinib for Human Epidermal Receptor 2-Positive Breast Cancer: A Meta-Analysis
Xiaona Lin, Xiao Liu, Xiaohui Yang and Feng Sun
[PDF]
Vol. 263, No. 3
pp.175-184, 2024
Regular Contributions
Successful Combination of Fresh Frozen Plasma and Albumin 5% in Plasma Exchange for a Patient with Concurrent Thyroid Storm and Guillain-Barré Syndrome: A Rare Case Report
Hanh-Duyen Bui-Thi, Thang Tran-Viet and Kim-Tu Trinh-Hoang
[PDF]
Vol. 263, No. 3
pp.169-173, 2024
Germacrone Protects against NF-κB-Mediated Inflammatory Signaling, Apoptosis, and Retinal Ganglion Cell Survival in a Rat Glaucoma Model
Yu Yuan and Linhai Shao
[PDF]
Vol. 263, No. 3
pp.185-193, 2024
Arsenic Trioxide Induces Retinoic Acid-Related Orphan Receptor Beta and Blocks the WNT Pathway to Inhibit Stemness in Glioblastoma
Dacheng Ding, Kaiming Gao, Xuebin Zhang and Hu Wang
[PDF]
Vol. 263, No. 3
pp.199-210, 2024
Letter to the Editor
Assessing Healthy Community Members’ Understanding of Prehabilitation
Mariko Sato, Mitsuru Ida and Masahiko Kawaguchi
[PDF]
Vol. 263, No. 3
pp.195-197, 2024
Primary Ciliary Dyskinesia with Identical Genotype but Distinct Phenotypes in Two Siblings
Megumi Sato, Yuji Fujita, George Imataka, Shigeko Kuwashima, Kazuhiko Takeuchi and Shigemi Yoshihara
[PDF]
Vol. 263, No. 3
pp.211-215, 2024



PUBLISHED BY TOHOKU UNIVERSITY MEDICAL PRESS, SENDAI, JAPAN